DDX41 MUTATIONS DEFINE A DISTINCT SUBTYPE OF MYELOID NEOPLASMS.
Introduction: Germline DDX41 variants have been implicated in late-onset myeloid neoplasms (MNs). Despite an increasing number of publications, many important features of DDX41-mutated MNs remain unclear. Methods: Here, we enrolled a total of 346 patients with DDX41 pathogenic/likely pathogenic (P/L...
Main Author: | H. Makishima |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221304892400027X |
Similar Items
-
P741: DDX41 MUTATIONS DEFINE A UNIQUE SUBTYPE OF MYELOID NEOPLASMS.
by: H. Makishima, et al.
Published: (2022-06-01) -
Current Understanding of <i>DDX41</i> Mutations in Myeloid Neoplasms
by: Kunhwa Kim, et al.
Published: (2023-01-01) -
PATHOGENIC MECHANISMS OF DDX41 MUTATIONS IN THE DEVELOPMENT OF MYELOID MALIGNANCIES
by: A. Kon, et al.
Published: (2024-01-01) -
P737: FUNCTIONAL ROLES OF DDX41 MUTATIONS IN THE DEVELOPMENT OF MYELOID MALIGNANCIES
by: A. Kon, et al.
Published: (2022-06-01) -
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome
by: Aref Al-Kali, et al.
Published: (2023-04-01)